Search

Search Constraints

You searched for: Author/Creator Rutgers, E.

Search Results

2. 250. Towards omitting breast cancer surgery in selective patient groups: Assessment of pathologic complete response after primary systemic treatment using multiple biopsies 'The MICRA trial'. Issue 9 (September 2016)

3. Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: a survey within the MINDACT cohort. (November 2022)

4. Clinical utility of MammaPrint testing in Invasive Lobular Carcinoma: Results from the MINDACT phase III trial. (October 2020)

5. Cost-effective strategies according to the first randomized trial comparing MRI breast cancer screening with mammography in women with a familial risk: FaMRIsc. (October 2020)

6. Early detection of breast cancer in high-risk women based on longitudinal changes in serum-based proteins: the TESTBREAST study. (November 2022)

7. FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe. Issue 2 (February 2021)